indogulf cropsciences ipo 2025: price band, dates & gmp update
Get the complete details of Indogulf Cropsciences IPO 2025 — issue size, price band, lot size, GMP, subscription status, and listing dates. Read expert review and market outlook.
Introduction to Indogulf Cropsciences IPO 2025
The Indian stock market is buzzing with excitement as Indogulf Cropsciences IPO 2025 opens its doors for subscription. This agrochemical manufacturing company is set to raise ₹200 crore through a fresh issue and offer for sale (OFS). With a diverse product range and solid market presence, Indogulf Cropsciences Limited (ICL) aims to capitalize on the growing demand for crop protection and plant nutrient products.
This article provides a detailed, structured guide covering everything you need to know — from IPO dates, price band, and financials to GMP trends and subscription advice.
Company Overview: Indogulf Cropsciences Limited
History and Business Profile
Founded in 1993, Indogulf Cropsciences Limited has evolved into a respected name in India’s agrochemical space. It manufactures a comprehensive range of products, including crop protection chemicals, specialty fertilizers, and bio-stimulants, catering to both domestic and international markets.
Product Portfolio and Operations
Indogulf operates four state-of-the-art manufacturing facilities across Haryana and Jammu & Kashmir, equipped for producing insecticides, herbicides, fungicides, plant nutrients, and biologicals. Its distribution network covers 22 Indian states, 3 Union Territories, and exports to 34 countries.
Competitive Strengths and Market Position
ICL’s key strengths lie in:
-
A well-diversified product range across three verticals.
-
A robust distribution network with over 5,700 distributors.
-
Backward-integrated, flexible manufacturing units.
-
Strong regulatory compliance and R&D infrastructure.
Indogulf Cropsciences IPO 2025 Key Details
IPO Opening and Closing Dates
The IPO opens for subscription on June 26, 2025 and closes on June 30, 2025.
Price Band and Face Value
The price band is fixed at ₹105-₹111 per share, with a face value of ₹10.
Lot Size and Investment Details
Retail investors can bid for a minimum of 135 shares, amounting to ₹14,985 at the cap price. The table below outlines the minimum and maximum investment for various categories:
| Category | Minimum Lot | Shares | Investment (₹) |
|---|---|---|---|
| Retail | 1 | 135 | 14,985 |
| S-HNI | 14 | 1,890 | 2,09,790 |
| B-HNI | 67 | 9,045 | 10,03,995 |
Promoters and Shareholding Pattern
Promoted by Om Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal, and Arnav Aggarwal, the pre-issue promoter shareholding stands at 96.86%, which will dilute post-issue.
Indogulf Cropsciences IPO Financial Performance
Revenue and Profit Trends
In FY23 and FY24, the company maintained a stable top line despite raw material price volatility, posting revenues of ₹555.79 crore and ₹466.31 crore respectively.
Key Financial Ratios and KPIs
As of March 31, 2024:
-
ROE: 12.2%
-
ROCE: 11.93%
-
Debt/Equity: 0.67
-
PAT Margin: 5.11%
Debt, Net Worth, and EBITDA Performance
With net worth increasing to ₹231.65 crore and an EBITDA of ₹55.74 crore in FY24, Indogulf has strengthened its financial base for future expansions.
Objectives of the Indogulf Cropsciences IPO
Funding Working Capital
₹65 crore is earmarked for working capital, enabling the company to manage inventory and receivables better.
Debt Repayment Plans
₹34.12 crore will go towards reducing existing debt, improving the company’s debt-equity ratio.
Capex for New DF Plant
₹14 crore is allocated for setting up a dry flowable plant in Barwasni, Haryana, boosting production capacity.
Indogulf Cropsciences IPO Reservation Details
The IPO follows a book-building process with the following reservation split:
| Investor Category | Percentage of Net Offer |
|---|---|
| Qualified Institutional Buyers (QIB) | Not more than 50% |
| Non-Institutional Investors (NII) | Not more than 15% |
| Retail Individual Investors (RII) | Not less than 35% |
This allocation strategy ensures retail investors have substantial participation opportunities, while institutional investors anchor the issue.
Grey Market Premium (GMP) and Expected Listing Gain
Latest GMP Updates and Trend Analysis
As of June 24, 2025, the Indogulf Cropsciences IPO GMP stands at ₹11. This is a positive indicator, suggesting a possible listing price of around ₹122 — nearly 9.91% premium over the cap price.
Estimated Listing Price and Potential Profit
At the cap price of ₹111, an investor could potentially earn ₹1,485 per lot on listing, subject to market conditions and oversubscription status.
How to Apply for Indogulf Cropsciences IPO 2025
Application via UPI and ASBA
Investors can bid through:
-
UPI-based applications via broker platforms or IPO apps.
-
ASBA facility via net banking for self-certified syndicate banks (SCSBs).
Applying Through Zerodha and Other Platforms
On Zerodha:
-
Log in to Console.
-
Go to ‘Portfolio’ > ‘IPO’.
-
Select Indogulf Cropsciences IPO 2025.
-
Enter bid details and UPI ID.
-
Accept mandate and submit.
Similar steps apply for Groww, Angel One, and other brokers.
IPO Timeline: Allotment and Listing Schedule
| Event | Date |
|---|---|
| IPO Opens | June 26, 2025 |
| IPO Closes | June 30, 2025 |
| Allotment Finalization | July 1, 2025 |
| Refund Initiation | July 2, 2025 |
| Credit of Shares to Demat | July 2, 2025 |
| Listing Date | July 3, 2025 |
Cut-off for UPI mandate confirmation is 5 PM on June 30, 2025.
Expert Reviews and Subscription Recommendations
As per market expert Dilip Davda, the IPO is “fully priced but offers long-term growth prospects in alignment with government initiatives supporting agriculture.” While the revenue stagnation over FY23 and FY24 poses caution, strong product demand and market presence balance this outlook.
Broker Consensus:
-
Subscribe: 1
-
Neutral: 0
-
Avoid: 0
Indogulf Cropsciences IPO Peer Comparison
While direct listed peers include UPL Limited and PI Industries, Indogulf Cropsciences stands out with its:
-
P/E (post IPO): 24.27
-
RoNW: 12.19%
Though smaller in scale, its niche market strategy, backward integration, and regulatory leverage make it competitive.
Risks and Factors to Consider Before Investing
-
Raw material price volatility impacting margins.
-
Highly regulated industry with stringent product approvals.
-
Debt burden, though being reduced via IPO proceeds.
-
Revenue stagnation over recent years.
-
IPO pricing at upper valuation range.
Investors should weigh these risks against growth potential in India's agribusiness sector.
Frequently Asked Questions (FAQs)
1️⃣ What is the Indogulf Cropsciences IPO 2025?
A ₹200 crore IPO comprising a fresh issue of ₹160 crore and an offer for sale of ₹40 crore in the agrochemical sector.
2️⃣ How to apply for Indogulf Cropsciences IPO through Zerodha?
Use Zerodha Console > Portfolio > IPO section to place your bid with UPI payment.
3️⃣ When will the Indogulf Cropsciences IPO open?
From June 26, 2025, to June 30, 2025.
4️⃣ What is the lot size and minimum investment?
One lot is 135 shares, requiring a minimum of ₹14,985.
5️⃣ When will the allotment and listing happen?
Allotment on July 1, 2025, and listing on July 3, 2025.
6️⃣ What is the current GMP for Indogulf Cropsciences IPO?
As of June 24, 2025, it’s ₹11 per share, signaling a 9.91% expected listing gain.
Conclusion: Should You Subscribe to Indogulf Cropsciences IPO 2025?
The Indogulf Cropsciences IPO 2025 presents a balanced opportunity — combining long-term growth potential in a sector aligned with India’s agri-focus policies, strong product diversification, and operational infrastructure. While fully priced and carrying moderate risks, the IPO has generated positive grey market sentiment, making it suitable for medium to long-term investors.
Recommendation:
Cautious Subscribe for those seeking exposure in the agrochemical segment with a tolerance for initial market volatility.
Disclaimer
The information provided in this article about Indogulf Cropsciences IPO 2025 is for informational and educational purposes only. It does not constitute financial, investment, or trading advice. Readers are advised to conduct their own research, consult with certified financial advisors, and carefully consider their individual risk profiles before making any investment decisions.
The IPO grey market premium (GMP) data, subscription status, and listing predictions shared here are based on publicly available information and market speculation, which are subject to change without prior notice. We do not participate in, trade, or endorse any grey market transactions.
Investing in stock markets involves risks, including the risk of loss. The author, this website, and its affiliates are not responsible for any financial losses arising out of investment decisions made based on this content.